Skip to main content
Signal8
Shah Vinay profile photo

Vinay Shah

CIK: 0001753078

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADIAL PHARMACEUTICALS, INC. logo
ADIL

ADIAL PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ADIAL PHARMACEUTICALS, INC. logo
    ADIL

    ADIAL PHARMACEUTICALS, INC.

    Apr 7, 2026
    Award(A)
    Direct
    17.3K shares-
  • ADIAL PHARMACEUTICALS, INC. logo
    ADIL

    ADIAL PHARMACEUTICALS, INC.

    May 29, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • ADIAL PHARMACEUTICALS, INC. logo
    ADIL

    ADIAL PHARMACEUTICALS, INC.

    Nov 16, 2024
    Award(A)

    Stock Option

    Direct
    40K shares-

1-3 of 3

About Shah Vinay

Shah Vinay (SEC CIK 0001753078) files insider reports with the SEC as Chief Financial Officer of ADIAL PHARMACEUTICALS, INC. (ADIL).

Signal8 holds 4 ownership filings by Shah Vinay (1 Form 3, 3 Form 4), filed between Nov 18, 2024 and Apr 9, 2026. Those filings report 3 transactions, from Nov 16, 2024 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Shah Vinay's filings is in GLEN ALLENVA, VA.

Recent filings by Shah Vinay

  • Apr 7, 2026: Grant or award of ADIL shares (Form 4, code A).
  • May 29, 2025: Grant or award of ADIL derivative securities (Form 4, code A).
  • Nov 16, 2024: Grant or award of ADIL derivative securities (Form 4, code A).

Other insiders filing for ADIAL PHARMACEUTICALS, INC. (ADIL)

How to read Form 4 transaction codes